Home > Healthcare > Medical Devices > Therapeutic Devices > Asthma Spacers Market

Asthma Spacers Market Size

  • Report ID: GMI8354
  • Published Date: Mar 2024
  • Report Format: PDF

Asthma Spacers Market Size

Asthma Spacers Market size was valued at around USD 1.66 billion in 2023 and is anticipated to register a CAGR of 5.5% between 2024 and 2032. Asthma spacers, also known as inhaler spacers or aerosol-holding chambers, are medical devices used in conjunction with metered-dose inhalers (MDIs) to improve the delivery of inhaled medications to the lungs for individuals with asthma or other respiratory conditions.

 

The rising incidence and prevalence of chronic respiratory conditions have become a significant public health concern globally. For instance, according to the World Health Organization (WHO) in 2019, asthma affected about 262 million people, resulting in 455,000 deaths. Thus, as the prevalence of chronic respiratory conditions, including asthma, continues to rise globally, there is a growing need for effective management and treatment options such as asthma spacers.
 

Furthermore, public, and private organizations are investing significantly in research and development activities aimed at innovating and improving various therapeutic respiratory devices. These investments stimulate the development of new and improved spacer devices with enhanced features, such as smart inhalers which is estimated to reach USD 3.3 billion by 2032, dose counters, anti-static chambers, and compact designs, which cater to the evolving needs of patients and healthcare providers.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Asthma spacers industry size was valued at USD 1.66 billion in 2023 and is estimated to reach over USD 2.67 billion by 2032, driven by the rising incidence and prevalence of chronic respiratory conditions.

The aerochamber product segment accounted for USD 641.5 million in 2023 and is set to gain traction by 2032, due to its role in reducing the amount of medication deposited in the mouth and throat and minimizing the risk of side effects such as oral thrush and hoarseness.

North America asthma spacers industry size was USD 672.2 million in 2023 and is predicted to witness substantial market growth by 2032, driven by a sophisticated healthcare infrastructure, an increasing prevalence of respiratory conditions such as asthma, rapid technological advancements.

Cipla Inc., GlaxoSmithKline plc, Koninklijke Philips N.V., Koo Medical Equipment, Laboratoire ProtecSom, Lupin Limited, Mediacare Equipments (India) Pvt. Ltd, Monaghan Medical Corporation, PARI GmbH are some of the major industry contenders.

Asthma Spacers Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 152
  • Countries covered: 22
  • Pages: 75
 Download Free Sample